FR940617-0-00058 FR940617-0-00009 21 CFR Parts 510 and 522 Animal Drugs, Feeds, and Related Products; Change of Sponsor AGENCY: Food and Drug Administration, HHS. ACTION: Final rule. SUMMARY: The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor for a new animal drug application (NADA) from Boehringer Ingelheim Animal Health, Inc., to Phoenix Scientific, Inc. EFFECTIVE DATE: June 17, 1994. FOR FURTHER INFORMATION CONTACT: Benjamin A. Puyot, Center for Veterinary Medicine (HFV&hyph;130), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301&hyph;594&hyph;1646. SUPPLEMENTARY INFORMATION: Boehringer Ingelheim Animal Health, Inc., 2621 North Belth Hwy., St. Joseph, MO 64506&hyph;2002, has informed FDA that it has transferred ownership of, and all rights and interests in NADA 99&hyph;169 for Oxytocin Injection to Phoenix Scientific, Inc., 3915 South 48th St. Terrace, P.O. Box 6457, St. Joseph, MO, 64506&hyph;0457. Accordingly, the agency is amending the regulations in 21 CFR 510.600(c)(1) and (c)(2) and in 21 CFR 522.1680(b) to reflect the change of sponsor. List of Subjects 21 CFR Part 510 Administrative practice and procedure, Animal drugs, Labeling, Reporting and recordkeeping requirements. 21 CFR Part 522 Animal drugs. Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR parts 510 and 522 are amended as follows: PART 510_NEW ANIMAL DRUGS 1. The authority citation for 21 CFR part 510 continues to read as follows: Authority: Secs. 201, 301, 501, 502, 503, 512, 701, 721 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321, 331, 351, 352, 353, 360b, 371, 379e). 2. Section 510.600 is amended in the table in paragraph (c)(1) by alphabetically adding a new entry for ``Phoenix Scientific, Inc.'' and in the table in paragraph (c)(2) by numerically adding a new entry for ``059130'' to read as follows: §510.600 Names, addresses, and drug labeler codes of sponsors of approved applications. * * * * * (c) * * * (1) * * * 1Firm name and address 1Drug labeler code ␣␣*␣␣␣*␣␣␣*␣␣␣*␣␣␣*␣␣ Phoenix Scientific, Inc. 3915 South 48th St. Terrace, P.O. Box 6457, St. Joseph, MO 64506&hyph;0457 059130 ␣␣*␣␣␣*␣␣␣*␣␣␣*␣␣␣*␣␣ (2) * * * 1Drug labeler code 1Firm name and address ␣␣*␣␣␣*␣␣␣*␣␣␣*␣␣␣*␣␣ 059130 Phoenix Scientific, Inc. 3915 South 48th St. Terrace, P.O. Box 6457, St. Joseph, MO 64506&hyph;0457 ␣␣*␣␣␣*␣␣␣*␣␣␣*␣␣␣*␣␣ PART 522_IMPLANTATION OR INJECTABLE DOSAGE FORM NEW ANIMAL DRUGS 3. The authority citation for 21 CFR part 522 continues to read as follows: Authority: Sec. 512 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360b). §522.1680 [Amended] 4. Section 522.1680 Oxytocin injection is amended in paragraph (b) by removing ``000010'' and ``and 058639'' and by adding ``058639, and 059130'' before the word ``in''. Dated: June 9, 1994. Robert C. Livingston, Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine. [FR Doc. 94&hyph;14708 Filed 6&hyph;16&hyph;94; 8:45 am] BILLING CODE 4160&hyph;01&hyph;F
